Analyst firms · UBS · ASML
UBS ASML price target and rating history
ASML Holding N.V. New York Registry Shares (ASML) · Technology
UBS rates ASML Holding N.V. New York Registry Shares (ASML) Buy, as of its latest action on Sep 5, 2025. It has published 3 rating actions on ASML since August 2022, including 2 upgrades and 1 downgrade.
- Current rating
- Buy
- Price target
- Not stated
- Median target, all firms
- Too few
- Actions on ASML
- 3
Every UBS rating on ASML
- Sep 5, 2025
- Sep 4, 2024DowngradeUBS downgrades to Neutral from Buy
- Aug 31, 2022
How other firms rate ASML
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| RBC Capital Markets | Outperform | $2,000 | Jul 14, 2026 |
| Barclays | Overweight | Jan 29, 2026 | |
| Bernstein | Outperform | $1,528 | Jan 5, 2026 |
Questions about UBS and ASML
- What is UBS's rating on ASML?
- UBS rates ASML Buy, a bullish rating, as of Sep 5, 2025.
- When did UBS last change its view on ASML?
- On Sep 5, 2025, UBS upgrades to Buy from Neutral.
More ASML rating histories
All UBS ratingsASML news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.